Delcath Systems Inc Drug Patent Portfolio
Delcath Systems Inc owns 1 orange book drug protected by 10 US patents Given below is the list of Delcath Systems Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9707331 | Apparatus for removing chemotherapy compounds from blood | 17 Sep, 2034 | Active |
| US9314561 | Filter and frame apparatus and method of use | 07 Feb, 2034 | Active |
| US10195334 | Filter and frame apparatus and method of use | 16 Jan, 2033 | Active |
| US11083831 | Filter and frame apparatus and method of use | 30 Dec, 2032 | Active |
| US11833286 | Filter and frame apparatus and method of use | 30 Dec, 2032 | Active |
| US10098997 | Apparatus for removing chemotherapy compounds from blood | 07 Nov, 2032 | Active |
| US10369264 | Apparatus for removing chemotherapy compounds from blood | 07 Nov, 2032 | Active |
| US10569004 | Apparatus for removing chemotherapy compounds from blood | 07 Nov, 2032 | Active |
| US11241522 | Apparatus for removing chemotherapy compounds from blood | 07 Nov, 2032 | Active |
| US11633528 | Apparatus for removing chemotherapy compounds from blood | 07 Nov, 2032 | Active |
Latest Legal Activities on Delcath Systems Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Delcath Systems Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Initial letter Re: PTE Application to regulating agency | 25 Apr, 2024 | US10369264 |
| Mail Patent eGrant Notification | 05 Dec, 2023 | US11833286 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Dec, 2023 | US11833286 |
|
Email Notification
Critical
| 05 Dec, 2023 | US11833286 |
| Recordation of Patent eGrant | 05 Dec, 2023 | US11833286 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Dec, 2023 | US11833286 |
| Patent eGrant Notification | 05 Dec, 2023 | US11833286 |
|
Email Notification
Critical
| 16 Nov, 2023 | US11833286 |
|
Issue Notification Mailed
Critical
| 15 Nov, 2023 | US11833286 |
|
Application Is Considered Ready for Issue
Critical
| 26 Oct, 2023 | US11833286 |
| Dispatch to FDC | 26 Oct, 2023 | US11833286 |
|
Issue Fee Payment Received
Critical
| 24 Oct, 2023 | US11833286 |
|
Issue Fee Payment Verified
Critical
| 24 Oct, 2023 | US11833286 |
| Patent Term Extension Application under 35 USC 156 Filed | 12 Oct, 2023 | US10369264 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 04 Oct, 2023 | US9314561 |
Delcath Systems Inc's Family Patents
Delcath Systems Inc Drug List
Given below is the complete list of Delcath Systems Inc's drugs and the patents protecting them.
1. Hepzato
Hepzato is protected by 10 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9707331 | Apparatus for removing chemotherapy compounds from blood |
17 Sep, 2034
(9 years from now)
| Active |
| US9314561 | Filter and frame apparatus and method of use |
07 Feb, 2034
(9 years from now)
| Active |
| US10195334 | Filter and frame apparatus and method of use |
16 Jan, 2033
(8 years from now)
| Active |
| US11083831 | Filter and frame apparatus and method of use |
30 Dec, 2032
(8 years from now)
| Active |
| US11833286 | Filter and frame apparatus and method of use |
30 Dec, 2032
(8 years from now)
| Active |
| US10098997 | Apparatus for removing chemotherapy compounds from blood |
07 Nov, 2032
(8 years from now)
| Active |
| US10369264 | Apparatus for removing chemotherapy compounds from blood |
07 Nov, 2032
(8 years from now)
| Active |
| US10569004 | Apparatus for removing chemotherapy compounds from blood |
07 Nov, 2032
(8 years from now)
| Active |
| US11241522 | Apparatus for removing chemotherapy compounds from blood |
07 Nov, 2032
(8 years from now)
| Active |
| US11633528 | Apparatus for removing chemotherapy compounds from blood |
07 Nov, 2032
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hepzato's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List